![]() |
|
|
J Hu, SZ Wang, C Forray and EE el-Fakahany
Division of Neuroscience Research in Psychiatry, University of Minnesota Medical School, Minneapolis 55455.
A large number of diverse pharmacological agents bind to a secondary domain on the muscarinic receptor, to influence allosterically the interaction of ligands at the primary binding site. Based on common structural features of these antagonists, we examined the interaction of protamine, an endogenous polycationic peptide, and of polyamines with muscarinic receptors in rat heart. Our results provide several lines of qualitative evidence that protamine allosterically modulates the conformation of muscarinic receptors, in a marked negatively cooperative manner. It decelerated the dissociation of N- [3H]methylscopolamine ([3H] NMS) initiated by atropine, in a concentration-dependent fashion. Inhibition by protamine of [3H]NMS binding at equilibrium showed a distinct plateau, which increased in magnitude at higher ligand concentrations. Scatchard analysis of saturation isotherms of [3H]NMS binding in the absence and presence of protamine indicated that protamine did not alter Bmax in a statistically significant fashion, although there was a trend of a concentration-dependent increase in this parameter. On the other hand, it caused a marked concentration-dependent decrease in the affinity of [3H]NMS, and this effect reached a ceiling limit. However, there were marked quantitative deviations of the interaction of protamine from a simple ternary allosteric model. Some of these discrepancies could be explained by the tendency of protamine to increase Bmax. The allosteric actions of protamine demonstrated in kinetic and equilibrium experiments were selective for m1 and m2 muscarinic receptors, compared with m3, m4, and m5 receptors, as studied in Chinese hamster ovary cells transfected with the genes of the different muscarinic receptors. Arginine residues play an important role in the allosteric interaction of protamine, inasmuch as poly-L-arginine qualitatively mimicked the effects of protamine. In contrast, no effects of the polyamines spermine, spermidine, and putrescine were observed on [3H]NMS binding. This is the first report on the allosteric modulation of muscarinic receptors by an endogenous peptide.
This article has been cited by other articles:
![]() |
N. Durcan, R. W. Costello, W. G. McLean, J. Blusztajn, B. Madziar, A. G. Fenech, I. P. Hall, G. J. Gleich, L. McGarvey, and M.-T. Walsh Eosinophil-Mediated Cholinergic Nerve Remodeling Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 775 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Selz, A. J. Mandell, M. F. Shlesinger, V. Arcuragi, and M. J. Owens Designing Human m1 Muscarinic Receptor-Targeted Hydrophobic Eigenmode Matched Peptides as Functional Modulators Biophys. J., March 1, 2004; 86(3): 1308 - 1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Christopoulos and T. Kenakin G Protein-Coupled Receptor Allosterism and Complexing Pharmacol. Rev., June 1, 2002; 54(2): 323 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Flacker and J. Y. Wei Endogenous Anticholinergic Substances May Exist During Acute Illness in Elderly Medical Patients J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2001; 56(6): M353 - M355. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. FRYER and D. B. JACOBY Muscarinic Receptors and Control of Airway Smooth Muscle Am. J. Respir. Crit. Care Med., November 1, 1998; 158(2007): S154 - S160. [Abstract] [Full Text] [PDF] |
||||
![]() |
R W Costello, D B Jacoby, and A D Fryer Pulmonary neuronal M2 muscarinic receptor function in asthma and animal models of hyperreactivity Thorax, July 1, 1998; 53(7): 613 - 618. [Full Text] |
||||
![]() |
S.-J. O, M. H. Cox, R. Mukherjee, M. J. Clair, F. A. Crawford Jr, and F. G. Spinale Direct and Interactive Effects of Cardioplegic Arrest and Protamine on Myocyte Contractility Ann. Thorac. Surg., August 1, 1996; 62(2): 489 - 494. [Abstract] [Full Text] |
||||
![]() |
R. B. Hird, T. W. Wakefield, R. Mukherjee, B. U. Jones, F. A. Crawford, P. C. Andrews, J. C. Stanley, and F. G. Spinale Direct Effects of Protamine Sulfate on Myocyte Contractile Processes : Cellular and Molecular Mechanisms Circulation, November 1, 1995; 92(9): 433 - 446. [Abstract] [Full Text] |
||||
![]() |
R. B. Hird, F. G. Spinale, K. W. Hewett, R. Mukherjee, and F. A. Crawford The direct effects of protamine sulfate on myocyte contractile processes J. Thorac. Cardiovasc. Surg., December 1, 1994; 108(6): 1100 - 1114. [Abstract] [Full Text] |
||||